Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients.
Int J Cardiol
; 168(1): 484-9, 2013 Sep 20.
Article
em En
| MEDLINE
| ID: mdl-23102599
Palavras-chave
Anti-LDL-oxidized antibodies; Atherosclerosis; BP; CAD; Coronary artery disease; HDL; LDL; MDA; MI; OxLDL; OxLDLAbs; Prognosis; antibodies anti-oxidized low density lipoprotein; blood pressure; coronary artery disease; high-density lipoprotein; low density lipoprotein; malondialdehyde; myocardial infarction; oxidized low density lipoprotein
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Imunoglobulina G
/
Doenças Cardiovasculares
/
Lipoproteínas LDL
/
Malondialdeído
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Int J Cardiol
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Itália